Featured
AgeX Therapeutics Skyrockets Up 250% After Juvenescence Discloses 50% Stake in AGE
AgeX leads the market with over 253 million shares being traded as the stock crosses $3 mark since July 2019.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.